Anita Afzali, MD, appointed secretary general of the World Gastroenterology Organisation

Anita Afzali, MD, professional portrait

Anita Afzali, MD

The University of Cincinnati College of Medicine's Anita Afzali, MD, professor and interim chair of the Department of Internal Medicine, has been named secretary general of the World Gastroenterology Organisation (WGO).

The WGO is the leading global organization for digestive health, representing more than 120 international member societies and more than 60,000 gastroenterologists worldwide. Its mission is to improve digestive health through education, training and advocacy — advancing innovation and addressing disparities across continents.

As secretary general, Afzali will guide WGO’s initiatives in education, mentorship and sustainable partnerships. This prestigious appointment showcases that internationally recognized gastroenterology expertise and leadership are not only shaping care worldwide but also right here at the University of Cincinnati and in the heart of Ohio.

“Our UC gastroenterology and hepatology programs deliver advanced, research-driven care that draws patients and collaborators from around the world,” said Afzali. “This role is both an honor and a responsibility. I am committed to strengthening global collaborations, expanding education and mentorship programs, and empowering the next generation of gastroenterology leaders.”

Learn more about the Department of Internal Medicine at the UC College of Medicine.

Featured image at top: CARE/Crawley building exterior on UC's medical campus. 

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.